SURVANTA(BERACTANT 25MG/ML)

Survanta Intratracheal is used to treat or prevent respiratory distress syndrome(RDS) in a premature baby whose lungs have not fully developed. Survanta Intratracheal may also be used for purposes not listed in this medication guide.

Category:

Description

Trade Name: 

SURVANTA

Manufacturer:

ABBOTT 

Presentation:

 INJECTION

Strength:

 

25MG/ML 

Pack Size:

 

PER VIAL 

Marketing Authorization Holder:

ABBOTT 

Composition:

Beractant (as phospholipids) 25mg/mL

Primary uses :

Respiratory distress syndrome

REQUEST FOR THE QUOTE

SURVANTA (BERACTANT 25MG/ML)

Product
Product
SURVANTA (BERACTANT 25MG/ML)

Disclaimer:

Trademark shown on our website are the property of their respective companies and exSell Laboratories Pvt Ltd does not have any claim on there brands. Parallel trade if any is conducted under the signed India Trips agreement which is mandated by the World Trade Organisation (WTO).